OZEM vs. GNOM ETF Comparison
Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to Global X Genomics & Biotechnology ETF (GNOM)
OZEM
Roundhill GLP-1 & Weight Loss ETF
OZEM Description
OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.
Grade (RS Rating)
Last Trade
$25.29
Average Daily Volume
37,622
14
GNOM
Global X Genomics & Biotechnology ETF
GNOM Description
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.Grade (RS Rating)
Last Trade
$9.83
Average Daily Volume
43,119
40
Performance
| Period | OZEM | GNOM |
|---|---|---|
| 30 Days | -10.60% | -8.90% |
| 60 Days | -11.17% | -13.16% |
| 90 Days | -12.25% | -14.89% |
| 12 Months | -5.98% |
0 Overlapping Holdings
| Symbol | Grade | Weight in OZEM | Weight in GNOM | Overlap |
|---|
OZEM Underweight 40 Positions Relative to GNOM
| Symbol | Grade | Weight | |
|---|---|---|---|
| VCYT | B | -4.69% | |
| CRSP | D | -4.66% | |
| NTRA | A | -4.41% | |
| ARWR | D | -4.31% | |
| TECH | F | -4.21% | |
| ILMN | C | -4.14% | |
| QGEN | D | -4.09% | |
| RNA | C | -4.06% | |
| BEAM | D | -4.03% | |
| A | D | -3.93% | |
| BNTX | C | -3.83% | |
| BMRN | F | -3.71% | |
| ALNY | D | -3.71% | |
| RARE | F | -3.63% | |
| LEGN | D | -3.56% | |
| SRPT | F | -3.55% | |
| NTLA | F | -3.23% | |
| MRNA | F | -3.13% | |
| TXG | F | -2.93% | |
| MYGN | F | -2.8% | |
| RCKT | F | -2.62% | |
| GILD | C | -2.17% | |
| CDNA | D | -2.13% | |
| VRTX | D | -2.09% | |
| VIR | D | -1.61% | |
| MRVI | F | -1.26% | |
| PACB | F | -1.18% | |
| SGMO | C | -0.99% | |
| RGNX | D | -0.95% | |
| ALLO | F | -0.79% | |
| VERV | F | -0.74% | |
| FLGT | F | -0.73% | |
| SANA | F | -0.65% | |
| QURE | D | -0.64% | |
| EDIT | F | -0.5% | |
| PSTX | D | -0.44% | |
| CRBU | D | -0.42% | |
| TSVT | F | -0.41% | |
| LYEL | F | -0.31% | |
| SCLX | F | -0.01% |
OZEM: Top Represented Industries & Keywords
GNOM: Top Represented Industries & Keywords
Compare ETFs
